| Symbol: |
KCTD9
|
| Description: |
potassium channel tetramerisation domain containing 9 [Source:HGNC Symbol;Acc:22401]
|
| Location: |
Chr8:25285366-25315992[-]
|
| CRmiRSNP:
~ Export ~
|
Records:null
| Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
| Compound:
~ Export ~
|
Records:161
| Gene |
Compound |
Gen_sig |
Exp_pattern |
| KCTD9 |
3-Phenacyliden-5-brom-2-indolinon |
0.039 |
Up |
| KCTD9 |
Hydrazinecarbodithioic acid, [1-(2-pyridinyl)ethylidene]-, phenylmethyl ester |
0.025 |
Up |
| KCTD9 |
Trichopolyn |
0.017 |
Up |
| KCTD9 |
Chlorazin |
0.036 |
Down |
| KCTD9 |
NSC 328130 |
0.042 |
Down |
| KCTD9 |
1-Piperazinecarboselenoic acid, 4-(2-pyridinyl)-, [1-(2-pyridinyl)ethylidene]hydrazide |
0.005 |
Up |
| KCTD9 |
ANTINEOPLASTIC-328785 |
0.04 |
Up |
| KCTD9 |
CYTOVARICIN |
0.043 |
Up |
| KCTD9 |
NSC 351351 |
0.005 |
Down |
| KCTD9 |
11H-Indeno[1,2-c]isoquinolinium, 9-hydroxy-2,3,8-trimethoxy-6-methyl-, chloride |
0.023 |
Down |
| KCTD9 |
Indeno[1,2-c]isoquinoline-5,11-dione, 6-methyl- 5-(methylsulfonyloxy)-5,6,6a,11a-tetrahydro- 2,3,8-trimethoxy-, cis- |
0.002 |
Down |
| KCTD9 |
ANTINEOPLASTIC-376265 |
0.011 |
Up |
| KCTD9 |
Maxima isoflavone D |
0.029 |
Down |
| KCTD9 |
NSC 401101 |
0.034 |
Up |
| KCTD9 |
NSC 40273 |
0.048 |
Down |
Expression pattern: Sensitivity / Resistance
Total:11 Current:2
First Prev Next Last 
|
| SNP:
~ Export ~
|
Records:55
Total:4 Current:1
[First] [Prev]  Next Last 
|
| miRNA:
~ Export ~
|
Records:3
| Gene |
Gen_transcript |
miRNA |
miR_location |
| KCTD9 |
ENST00000380697 |
hsa-mir-217 |
Chr2:56210155-56210177[-] |
| KCTD9 |
ENST00000380697 |
hsa-mir-374b-3p |
ChrX:73438392-73438413[-] |
| KCTD9 |
ENST00000380697 |
hsa-mir-448 |
ChrX:114058087-114058108[+] |
Total:1 Current:1
[First] [Prev] [Next] [Last]
|